AG0038TR

32780-64-6 | 2-Hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide HCl

Chemical structure of 2-Hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide HCl, CAS 32780-64-6
AG0038TR
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 32780-64-6
Catalog Number AG0038TR(AGN-PC-0R85PC)
Chemical Name 2-Hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide HCl
IUPAC Name 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride
InChI InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H
InChI Key WQVZLXWQESQGIF-UHFFFAOYSA-N
MDL Number MFCD00057663
Molecular Formula C19H25ClN2O3
Molecular Weight 364.8664
SMILES CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=O)N)O)O.Cl
UNII 1GEV3BAW9J
Synonyms
AH 5158, AH-5158, AH5158, Albetol, Apo Labetalol, Apo-Labetalol, ApoLabetalol, Dilevalol, Hydrochloride, Labetalol, Labetalol, Labetalol Hydrochloride, Labetalol, (R,R)-Isomer, Labetolol, Normodyne, Presolol, R,R Labetalol, R,R-Labetalol, SCH 19927, SCH-19927, SCH19927, Trandate, Labetalol hydrochloride, 32780-64-6, Labetalol HCL, Amipress, Presdate, Labrocol, Pressalolo, Ipolab, Labetalol (hydrochloride), 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide hydrochloride, UNII-1GEV3BAW9J, AH 5158A, Sch-15719W, ScH 15719W, CCRIS 1086, Labetalol hydrochloride, EINECS 251-211-1, 1GEV3BAW9J, NSC 290312, MLS000069666, AH-5158A, MFCD00057663, SMR000058463, 5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide hydrochloride, 5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide hydrochloride, 2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide hydrochloride, 5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride, DSSTox_CID_24654, DSSTox_RID_80378, Salicylamide, 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, hydrochloride, DSSTox_GSID_44654, C19H25ClN2O3, 5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide monohydrochloride, Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, monohydrochloride, Benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride(1:1), AH-5158, SR-01000000209, C19H24N2O3.HCl, labetalol-hcl, 2-hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide hydrochloride, 2-Hydroxy-5-(1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl)benzamide hydrochloride, 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide hydrochloride, 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride, Normodyne (TN), Trandate (TN), Prestwick_290, EINECS 276-694-6, Labetalol hydrochloride [USAN:JAN], Labetalol hydrochloride [USAN:USP:JAN], AC1Q5DEI, AH-5158 hydrochloride, La.beta.lol hydrochloride, Opera_ID_1625, Benzamide,monohydrochloride, NCGC00016810-01, Salicylamide, hydrochloride, CAS-32780-64-6, SCHEMBL41230, MLS001148626, MLS002222197, SPECTRUM1503243, AC1L2G48, CHEBI:6344, CHEMBL1200323, DTXSID0044654, CTK4G9285, KS-00000GGU, AOB5072, WQVZLXWQESQGIF-UHFFFAOYSA-N, HMS1568H16, HMS1922M13, Pharmakon1600-01503243, BCP13886, HY-B1108, Tox21_110623, Tox21_302725, Tox21_500687, CCG-40314, Labetalol hydrochloride (JP17/USP), NSC290312, NSC758438, s4291, AKOS015895575, AC-1389, API0003104, CS-4706, LP00687, NC00571, NSC-290312, NSC-758438, SS-4219, VA11135, NCGC00094044-01, NCGC00094044-02, NCGC00094044-03, NCGC00094044-04, NCGC00094044-05, NCGC00256847-01, NCGC00261372-01, (R*,R*)-(1)-5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride, 72487-34-4, AK144692, AN-14950, BC678573, CPD000058463, Labetalol HCl (Mixture of Diastereomers), LS-26937, SAM002564217, SC-58270, AX8135749, ST2410032, 4CH-016313, EU-0100687, FT-0630564, SW196595-3, D00600, J10319, Labetalol hydrochloride, >98% (TLC), powder, 780L646, C-20992, I06-0868, SR-01000000209-2, SR-01000000209-7, 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide HCl, 2-Hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide HCl, Labetalol hydrochloride, European Pharmacopoeia (EP) Reference Standard, Labetalol hydrochloride, United States Pharmacopeia (USP) Reference Standard, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide hydrochloride, Labetalol Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-,monohydrochloride, Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride (1:1), Normodyne, Trandate, NORMOZIDE, Dilevalol hydrochloride, labetolol Hydrochloride, TRANDATE HCT, Benzamide, monohydrochloride, C19H24N2O3.ClH, CID71412, C19-H24-N2-O3.Cl-H, AR-1G6710, CL0011, 32780-64-6 (HCl), L 1011, (R*,R*)-(+-)-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide monohydrochloride, 33588-16-8, Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, monohydrochloride,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited